These findings suggest that a novel ATX/ENPP2 inhibitor, ONO-8430506, may have a favorable effect on urethral obstructive diseases, in addition to other diseases, such as cancer, fibrosis, and rheumatism, where the causal relationship of ATX/ENPP2 has already been established. This evidence concerns the gene ENPP2 and cancer.